logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Sunday, August 17, 2025 · 840,595,183 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Drug Design News Monitoring

  • Published on 10:29 GMT

    MIT scientists use AI to develop new antibiotics for stubborn gonorrhoea and MRSA

    Published on 15/08/2025 - 12:36 GMT+2 Scientists have used artificial intelligence (AI) to create potential new drugs for so-called superbugs – stubborn bacterial infections that can evade existing treatments. AI has reshaped drug discovery in …

    Source: Euronews - Neutral
  • Published on 07:01 GMT

    Learn AI for Free: Education Ministry Introduces 5 Courses On SWAYAM

    Have you ever wondered why more and more students are choosing to study Artificial Intelligence these days? The reason is clear — AI is no longer just a buzzword, it is a skill that helps shape the future of industries around the world. From healthcare and …

    Source: Zee News - Right-wing
  • Published on Aug 16, 2025

    MIT AI Designs Novel Antibiotics to Combat MRSA Resistance

    In the rapidly evolving field of drug discovery, a groundbreaking advancement from MIT researchers is harnessing generative artificial intelligence to combat one of medicine’s most pressing challenges: antibiotic-resistant bacteria. By designing novel …

    Source: WebProNews - Pending
  • Published on Aug 16, 2025

    MIT Researchers Use AI for Developing New Antibiotics for Superbugs

    MIT scientists have harnessed generative AI to revolutionize antibiotic discovery, unveiling two novel compounds capable of combating drug-resistant gonorrhoea and MRSA. By designing these drugs atom-by-atom and venturing beyond known chemical structures, …

    Source: Top News - Pending
  • Published on Aug 16, 2025

    EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

    The European Medicines Agency (EMA) has granted orphan designation to rilzabrutinib, an investigational oral Bruton’s tyrosine kinase (BTK) inhibitor from Sanofi (1). The designation applies to the treatment of IgG4-related disease (IgG4-RD). Orphan …

    Source: Pharmaceutical Technology - Neutral
  • Published on Aug 16, 2025

    Advancing Precision Cancer Therapy Through Tumor Electrophysiology Insights

    In recent years, the landscape of cancer therapy has witnessed a transformative shift towards precision oncology, with an emerging frontier rooted in the electrophysiological properties of tumors. Tumor cells exhibit distinctive bioelectrical …

    Source: Bioengineer.org - Indeterminate
  • Published on Aug 16, 2025

    How AI and supercomputers could revolutionise personalised medicine

    The combination of artificial intelligence, advanced molecular modelling and genomic sequencing could transform medicine. With the right investment, the UK could lead this change, writes Professor Syma Khalid of the University of Oxford Artificial …

    Source: The European Magazine - Neutral
  • Published on Aug 16, 2025

    MIT AI Designs Antibiotics to Fight Drug-Resistant Gonorrhea and MRSA

    Breakthrough in AI-Driven Drug Discovery In a pivotal advancement for combating antimicrobial resistance, researchers at the Massachusetts Institute of Technology have harnessed generative artificial intelligence to design novel antibiotics targeting drug- …

    Source: WebProNews - Pending
  • Published on Aug 15, 2025

    Precision Nanobody Therapy Breaks New Ground in Targeting Lung Cancer Tumors

    A pioneering breakthrough in cancer therapy has emerged from the laboratories of the Korea Research Institute of Bioscience and Biotechnology (KRIBB), where a team led by Dr. Juyeon Jung at the Bio-Nano Research Center has developed a revolutionary …

    Source: Bioengineer.org - Indeterminate
  • Published on Aug 15, 2025

    AI designs drugs to combat gonorrhoea and MRSA

    Artificial intelligence has helped researchers to design antibiotics that can tackle hard-to-treat infections gonorrhoea and MRSA. A team at Massachusetts Institute of Technology used AI algorithms to design more than 36 million possible compounds and …

    Source: STV News - Neutral
  • Published on Aug 15, 2025

    MIT AI Designs Novel Antibiotics to Fight Drug-Resistant Superbugs

    In a groundbreaking fusion of artificial intelligence and microbiology, researchers at the Massachusetts Institute of Technology have harnessed generative AI to design novel antibiotics capable of targeting some of the world’s most stubborn drug-resistant …

    Source: WebProNews - Pending
  • Published on Aug 15, 2025

    Rewrite PD-1 + IL-2 power couple: Wake up ‘sleepy’ T cells to turbo-charge cancer cures this news headline for the ...

    image: PD-1/IL-2 bifunctional molecules block PD-1i mmunosuppressive signals while cis-activating T cells. view more  Credit: ©Science China Press Researchers at Peking Union Medical College Hospital have mapped out why pairing two well-known cancer …

    Source: Bioengineer.org - Indeterminate
  • Published on Aug 15, 2025

    The Re-humanization and Democratization of Health Care

    In a wide-ranging and illuminating conversation with the Dana-Farber Cancer Institute's exceptional duo of Drs. Ben Ebert and Eli van Allen on the role they see for AI in medical practice, and oncology specifically, there was a moment when the dialogue …

    Source: Newsweek - Left-wing
  • Published on Aug 15, 2025

    Education Ministry Launches 5 Free AI Courses on SWAYAM Platform

    Free SWAYAM courses to help students apply AI in fields from sports to science and commerce Education Correspondent info@impressivetimes.com The Ministry of Education has rolled out a special opportunity for students keen to explore the world of Artificial …

    Source: The Impressive Times - Pending
  • Published on Aug 15, 2025

    Generative AI boost in battle against drug resistance

    Generative AI has enabled the creation of novel antibiotics capable of killing two highly drug resistant infections. Massachusetts Institute of Technology (MIT) scientists described in the journal Cell how they harnessed artificial intelligence to combat a …

    Source: Laboratory News - Neutral
  • Published on Aug 15, 2025

    AI could lead to 'golden age' of antibiotics

    Artificial intelligence could hold the key to turning back the rising tide of antimicrobial resistance (AMR), according to researchers at Massachusetts Institute of Technology. Researchers from MIT have used generative AI (genAI) algorithms to design novel …

    Source: pharmaphorum - Neutral
  • Published on Aug 15, 2025

    How AI is Accelerating the Development of RNA Vaccines and Therapies

    In a groundbreaking advancement poised to reshape the future of RNA therapeutics, researchers at the Massachusetts Institute of Technology have harnessed the power of artificial intelligence to revolutionize the design of lipid nanoparticles (LNPs). These …

    Source: Bioengineer.org - Indeterminate
  • Published on Aug 15, 2025

    TuHURA R&D Jumps 75% in Q2

    TuHURA Biosciences (HURA -2.82%), a biotechnology company focused on immuno-oncology therapies, released its second quarter results on August 14, 2025. The big headlines included the start of a pivotal Phase 3 clinical trial for IFx-2.0, a new product …

    Source: myMotherLode - California - Pending
  • Published on Aug 15, 2025

    AI breakthrough creates new antibiotics for superbugs

    The generative AI sifted through more than 36 million molecular compounds and pinpointed two new drugs, later tested in vitro and in animal models. These leading candidates are structurally distinct from existing antibiotics and appear to act via novel …

    Source: Gulf News - Gov't Propaganda

01 days 16:35:10

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 840,595,183 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 08/16/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy

By continuing to use this site, you agree to our Terms & Conditions, last updated on July 21, 2025.

We use cookies to enhance your experience. Learn more